Saline and silicone-gel implants are the main options patients discuss, but implant type alone cannot predict whether another operation will be needed. The FDA reports that about 1 in 2 breast reconstruction patients have their implants removed within 10 years. This estimate comes from long-term implant studies and describes removal, not a guaranteed need for replacement. That distinction matters.
Removal may mean exchanging an implant, taking it out without replacement, or addressing a complication. Reasons can include capsular contracture, rupture, infection, or a patient’s changing preferences. The FDA also cautions that breast implants are not lifetime devices; the chance of complications and additional surgery rises with time. Its estimate is a useful population-level signal, not an individual forecast.
For a practical discussion, ask the surgeon what the 10-year figure means for your situation, and whether it includes removal without replacement. Ask how follow-up imaging, symptoms, and personal medical history affect the plan. A firm, painful breast or a sudden change in shape deserves medical assessment, not guesswork. The FDA’s “Risks and Complications of Breast Implants” guidance and its long-term core clinical study data are useful references. The numbers are imperfect: study populations and follow-up differ, and some patients may need surgery earlier or never. That uncertainty should be part of informed consent.
MGMT Orthopedic Implants